Abstract:The phenomenon of protein aggregation into amyloid fibrils is associated with a large number of major diseases of unrelated etiology. Unraveling the mechanism of amyloid self-assembly and identifying therapeutic directions to control this process are of utmost importance. Research in this field has been hampered by several challenges, including reproducibility, low protein purification yields, and the inherent aggregation propensity of amyloidogenic proteins, making them extremely difficult to study. Herein, on the basis of the similarity in the assembly mechanism, as well as the physical, chemical, and biological characteristics, of diphenylalanine nanostructures and aromatic amino acid containing amyloid fibrils, we report a simple, yet robust peptide-based platform that could be used for screening of small molecules potentially capable of interfering with the aggregation process and for mechanistic exploration of their mode of action. The system was validated using four small-molecule inhibitors, and the effect was examined via turbidity assay, thioflavin T fluorescence, and electron microscopy. The aggregation profile of diphenylalanine was very similar to that of β-amyloid polypeptide in the presence of the modulators. Rosmarinic acid emerged as an extremely potent inhibitor and a destabilizer of the aggregates. The effect of stoichiometric variation of rosmarinic acid on the process of destabilization was also probed using a microfluidic technique. Finally, the formation of equimolar complexes of diphenylalanine and inhibitors was detected using mass spectrometry. This approach not only provides a system for high-throughput screening of possible inhibitor molecules from larger libraries of modulators, but is also highly useful for understanding the mechanistic aspects of the interactions leading to the process of inhibition.

Amyloids, amorphous aggregates and assemblies of peptides – Assessing aggregation

Molecular Simulations of Amyloid Structures, Toxicity, and Inhibition

The Molecular Lifecycle of Amyloid – Mechanism of Assembly, Mesoscopic Organisation, Polymorphism, Suprastructures, and Biological Consequences

Potassium Ion Mediated Double‐Layered Upright Assembly of Negatively Charged Amyloid‐Like Peptides at Mica/Water Interface

Amyloid Aggregation: Role of Biological Membranes and the Aggregate-Membrane System

Exploring the Early Steps of Aggregation of Amyloid-Forming Peptide Kffe

Pathways of hLL-3717-29 Aggregation Give Insight into the Mechanism of α-Amyloid Formation

Energy Landscapes of the Monomer and Dimer of the Alzheimer’s Peptide Aβ(1–28)

Insights into Amyloid Structural Formation and Assembly Through Computational Approaches.

Polymorphism in Alzheimer Aβ Amyloid Organization: Insight into Aβ Aggregation

Amyloid-based nanosensors and nanodevices

Peptide Self-Assembly into Amyloid Fibrils: Unbiased All-Atom Simulations

Diphenylalanine as a Reductionist Model for the Mechanistic Characterization of β-Amyloid Modulators

Molecular Mechanism of the Early Stage of Amyloidogenic Hexapeptides (NFGAIL) Aggregation

Experimental Characterization of Disordered and Ordered Aggregates Populated During the Process of Amyloid Fibril Formation.

Computational studies of protein aggregation mediated by amyloid: Fibril elongation and secondary nucleation

Investigation of supramolecular structures in various aqueous solutions of an amyloid forming peptide using small-angle X-ray scattering

Competition between crystal and fibril formation in molecular mutations of amyloidogenic peptides

Role of Monomer Arrangement in the Amyloid Self-Assembly.

Model for competing pathways in protein-aggregation: role of membrane bound proteins

Compilation and Analysis of Enzymes, Engineered Antibodies, and Nanoparticles Designed to Interfere with Amyloid-Beta Aggregation